US Patent Issued to BIOTHEUS on Oct. 27 for "Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,346, issued on Oct. 27, was assigned to BIOTHEUS INC. (Zhuhai, China).

"Anti-CEACAM5 monoclonal antibody and preparation method thereof and use thereof" was invented by Shifu Mo (Shanghai), Wei Xu (Shanghai), Yi Luo (Zhuhai, China) and Liandi Chen (Zhuhai, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are a monoclonal antibody and antigen-binding fragment thereof which can specifically bind to human carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5); also disclosed is a chimeric antigen receptor based on said antibody, and a method for preparing said antibody and antigen-binding fragment and use thereof for treating...